Cancer Immunology – News and Features

The cell line designed expresses monoclonal antibodies that have been vital for the success of a clinical trial ran by Alligator Biosciences.

Selected for a highly specialized vaccine fill / finish project.

A genetically engineered herpes virus can halt the progression of skin cancer by killing cancer cells and sparking the immune system into action against tumours, a landmark clinical trial has shown.

This recently announced partnership will see the companies jointly research, develop and commercialize cancer immunotherapies.

Researchers at Trinity College Dublin and the University of Pennsylvania have uncovered an important link between our body clock and the immune system that will have relevance to the treatment of inflammatory and infectious diseases.

Expansion to support commercial-scale gene therapy production, testing and filling.

Research collaboration to discover novel cancer immunotherapies.

A mouse’s T cells can be primed to attack and eliminate a malignant tumor by injecting antibodies from another mouse with resistance to the tumor, as well as by activating certain signaling cells, a study has found.

Results on ARGX-115 published in Science Translational Medicine indicating inhibition of immune checkpoint GARP in in vivo mouse model.

Reicin brings extensive experience in R&D as a senior leader in biopharma.